Our group has recently shown that IL-9 prolongs the survival of neutrophils, enhances the production of matrix metalloprotienase-9, and facilitates the differentiation of TH17 cells, thus indicating its pathogenic role in RA [86]. This evidence concerns the gene IL9 and rheumatoid arthritis.